A股異動 | 倍加潔漲停 擬4.71億元收購薇美姿16.49%股份
格隆匯2月3日丨倍加潔(603059.SH)高開高走漲停,報22.51元,創去年2月份以來新高,總市值22.5億。公司昨日公吿稱,與北京君聯、北京翰盈簽署了《關於薇美姿實業(廣東)股份有限公司之股份轉讓協議》,擬以現金方式收購北京君聯、北京翰盈持有的薇美姿共計16.4967%的股權,交易對價4.71億元。薇美姿是國內領先的口腔護理用品提供商,薇美姿旗下“舒客”品牌為中國高知名度口腔護理品牌。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.